The scientific methods of toxicology are most often used to identify potential hazards or to evaluate the safety of specific substances under certain experimental conditions. Although current scientific risk assessments are quantitative in nature, they are based upon assumptions inherent in methods of safety evaluation and hazard identification.
To date, the predominant method is to test animals and then to extrapolate the results to humans. Interspecies extrapolations indude route of exposure, dose, and response. Due to the lack of information about relevant human responses to chemical exposures, such extrapolations lead to uncertainties; these uncertainties result in decreased confidence in risk estimates. Even in tier test systems that are significantly based on alternative tests, confirmation is obtained through selective testing in animal species. In vitro data are often viewed as an additional level of extrapolation. In such schemes, in vitro data may be used to bolster knowledge about specific issues of extrapolation, but the data themselves represent an additional source of uncertainty (Fig. 1A ) (1) (2) (3) (4) (5) (6) .
In this workshop we considered an alternate scheme, based on the parallelogram approach to extrapolation to man, that was proposed in the late 1970s by Sobels (7) (8) (9) . Although this approach was originally described for its application to chemical mutagenesis, its underlying principal, "to obtain information on damage that is hard to measure directly" (8) , is relevant to most, if not all, biological endpoints of toxicity. In Figure 1B , the parallelogram has been modified to emphasize two important issues that were considered in this workshop: interspecies and in vitro-in vivo extrapolation. This parallelogram provides a framework for the discussion of molecular and cellular approaches to extrapolation for risk assessment and provides a process for systematic, comparative biology. In vitro data are used to support investigations of mechanism of action and, more specifically, to evaluate the assumption of conserved mechanism of action among different species. By superimposing the parallelogram onto the components of toxicity identified in Figure 2, Figure 2 , complex processes can be subdivided into discrete components that provide a context for investigations of specific mechanistic steps. While each individual component is truly a connected series of mechanistic steps, the broader picture depicted in Figure 2 emphasizes that, for the current status of risk assessments, it may be more useful to obtain increased knowledge of the entire process, albeit at a less comprehensive level, than it is to have complete knowledge about one or more steps in the process, with little knowledge of others. In general, the overall assessment will only be as good as the least understood component in the mechanism of the endpoint of interest.
Several speakers raised an interesting question concerning prediction: are the responses observed in rodents valid predictors of human toxicity? As discussed above, the parallelogram provides a framework in which to test the hypothesis of conserved mechanism of action among different species.
Molecular and cellular approaches, combined with comparative in vitro systems, provide a method to explore early biological responses to chemical or physical agents and the role of these early effects in altered cellular structure and function. Such studies may lead to an improved understanding of mechanism of action and biological determinants of specificity. Also, --iRf#*..e. 9 e---- (8) to emphasize the issues of interspecies and in vitro-in vivo extrapolation. In this four-cornered experimental approach to knowledge of mechanism, in vitro data is used to test the hypothesis that a specific mechanism of action is conserved among rodent and human species. Note that the alternate hypothesis will still provide information about the action of the test compound in humans. studies of the relationship between concentration and biologically effective dose may provide insights into the shape of the dose-response curve in humans, including even lower levels of exposure. The potential for this latter opportunity (high to low dose) comes from the sensitivity of biological endpoints that are based on specific molecular and cellular targets.
In terms of linking exposure to dose-response relationships, several significant advancements have been made in the area of physiologically based pharmacokinetic (PBPK) and pharmacodynamic modeling. The concept of surrogate dose, or dose at the site of molecular action, provides a bridge between in vivo exposure and specific biological responses measured either in vivo or in vitro. As such, these modeling techniques may provide a continuum in investigations of mechanism, as experimental systems move between animals and cells in culture (10) .
Human Cells
At present, the mechanism of action of many chemicals in humans is not fully understood. This Mechanism-based approaches to risk assessment tend toward identification of true risk. Risk assessments that are based on such information will be based on the best available science. In turn, this should motivate good research and promote a self-advancing field that provides an improved understanding of human risk. Computer-based chemical databases facilitate the collection, storage, and retrieval of large amounts of information. Inherent in these chemical structures are features that determine biological activity (19) . Studies of structure activity relationships provide the opportunity to advance from chemical specific risk assessments to chemical dass-based risk assessments. Both the concepts of structure activity and surrogate dose imply the presence of a critical cellular target. Mechanism-based approaches implore the identification of such targets and raise the question of their conservation among species.
Regulatory Agencies and Risk Assessment
Several issues were identified that relate to certainty and uncertainty in risk estimates. Currently, both the regulatory and legal systems attempt to classify everything as safe or hazardous. Is it possible to move away from this toward a weight-of-evi-I -SUM 9 . 
